CDKN2A and cancer: This demonstrated that α6β1/α6β4 integrin signaling together with Arf associated pathways were found to be activated, whereas regulators of diverse cellular responses, including cell cycling, survival, and differentiation were suppressed in the 9 cancer types relative to their corresponding normal tissues.